cated to the thriving field of Molecular Medicine. EMBO Molecular Medicine publishes original research at the interface between molecular biology and clinical research that is highly relevant to understand, prevent and treat human diseases.
Launching a journal is an exciting challenge. All of us at the European Molecular Biology Organization (EMBO) and our publisher Wiley have high ambitions for this new venture. We are thus particularly proud to present our first issue that embodies much of what we want our Journal to be. It brings you high quality, stimulating science; illustrating our broad scope, this month's research articles report on a mouse model for a behavioural syndrome that provides new insights into the molecular basis of the human phenotypes, an analysis of the remarkable mode of action of a novel antibiotic and exciting data that open up potential innovative treatments of cancer and inherited respiratory deficiencies. Our attractive front-half section will cover a variety of topics central to the Molecular Medicine community and will alert you to news, developments and trends in the area. In this issue, you can find out our views on the Journal and the field by reading our 'Editorials', we feature a 'Closeup' article highlighting one of our papers, an 'In Focus', a short topical piece, discussing the threats posed by haemorrhagic fever viruses and a 'Review' calling your attention to the so far neglected role of dendritic cells in tuberculosis and proposing new targets to fight this disease.
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